Comparison of microbial hosts and expression systems for mammalian CYP1A1 catalysis

被引:12
作者
Cornelissen, Sjef [1 ]
Julsing, Mattijs K. [1 ]
Schmid, Andreas [1 ]
Buehler, Bruno [1 ]
机构
[1] TU Dortmund Univ, Dept Biochem & Chem Engn, Lab Chem Biotechnol, D-44227 Dortmund, Germany
关键词
Cytochrome P450 1A1; 7-Ethoxyresorufin O-deethylation; Whole-cell biocatalysis; Gene expression; Escherichia coli; CYTOCHROME P450 REDUCTASE; MONOXIDE-BINDING PIGMENT; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; LIVER MICROSOMES; HETEROLOGOUS EXPRESSION; ENZYMATIC-PROPERTIES; FISSION YEAST; IN-VITRO; PURIFICATION;
D O I
10.1007/s10295-011-1026-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mammalian cytochrome P450 enzymes are of special interest as biocatalysts for fine chemical and drug metabolite synthesis. In this study, the potential of different recombinant microorganisms expressing rat and human cyp1a1 genes is evaluated for such applications. The maximum specific activity for 7-ethoxyresorufin O-deethylation and gene expression levels were used as parameters to judge biocatalyst performance. Under comparable conditions, E. coli is shown to be superior over the use of S. cerevisiae and P. putida as hosts for biocatalysis. Of all tested E. coli strains, E. coli DH5 alpha and E. coli JM101 harboring rat CYP1A1 showed the highest activities (0.43 and 0.42 U g(CDW)(-1), respectively). Detection of active CYP1A1 in cell-free E. coli extracts was found to be difficult and only for E. coli DH5 alpha, expression levels could be determined (41 nmol g(CDW)(-1)). The presented results show that efficient expression of mammalian cyp1a1 genes in recombinant microorganisms is troublesome and host-dependent and that enhancing expression levels is crucial in order to obtain more efficient biocatalysts. Specific activities currently obtained are not sufficient yet for fine chemical production, but are sufficient for preparative-scale drug metabolite synthesis.
引用
收藏
页码:275 / 287
页数:13
相关论文
共 77 条
[21]   STUDIES ON TRANSFORMATION OF ESCHERICHIA-COLI WITH PLASMIDS [J].
HANAHAN, D .
JOURNAL OF MOLECULAR BIOLOGY, 1983, 166 (04) :557-580
[22]  
Hanlon S.P., 2007, Modern Biooxidation, P233, DOI DOI 10.1002/9783527611522.CH10
[23]   The development of an efficient system for heterologous expression of cytochrome P450s in Escherichia coli using hemA gene co-expression [J].
Harnastai, IN ;
Gilep, AA ;
Usanov, SA .
PROTEIN EXPRESSION AND PURIFICATION, 2006, 46 (01) :47-55
[24]   Solvent-tolerant bacteria for biotransformations in two-phase fermentation systems [J].
Heipieper, Hermann J. ;
Neumann, Grit ;
Cornelissen, Sjef ;
Meinhardt, Friedhelm .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 74 (05) :961-973
[25]   TRANSFORMATION OF YEAST [J].
HINNEN, A ;
HICKS, JB ;
FINK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :1929-1933
[26]   Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future [J].
Ingelman-Sundberg, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (04) :193-200
[27]   High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli [J].
Iwata, H ;
Fujita, K ;
Kushida, H ;
Suzuki, A ;
Konno, Y ;
Nakamura, K ;
Fujino, A ;
Kamataki, T .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) :1315-1325
[28]  
JamisDow CA, 1995, CANCER CHEMOTH PHARM, V36, P107
[29]   Heme-iron oxygenases:: powerful industrial biocatalysts? [J].
Julsing, Mattijs K. ;
Cornelissen, Sjef ;
Buehler, Bruno ;
Schmid, Andreas .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) :177-186
[30]   Targeting of active human cytochrome P4501A1 (CYP1A1) to the periplasmic space of Escherichia coli [J].
Kaderbhai, MA ;
Ugochukwu, CC ;
Lamb, DC ;
Kelly, SL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (03) :803-807